| Item | Property | Value | Comments | 
|---|
 include | http://hl7.org/fhir/sid/cvx |  |  | 
  Concept | 01 | diphtheria, tetanus toxoids and pertussis vaccine |  | 
  Concept | 02 | trivalent poliovirus vaccine, live, oral |  | 
  Concept | 03 | measles, mumps and rubella virus vaccine |  | 
  Concept | 04 | measles and rubella virus vaccine |  | 
  Concept | 05 | measles virus vaccine |  | 
  Concept | 06 | rubella virus vaccine |  | 
  Concept | 07 | mumps virus vaccine |  | 
  Concept | 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |  | 
  Concept | 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
  Concept | 10 | poliovirus vaccine, inactivated |  | 
  Concept | 100 | pneumococcal conjugate vaccine, 7 valent |  | 
  Concept | 101 | typhoid Vi capsular polysaccharide vaccine |  | 
  Concept | 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |  | 
  Concept | 103 | meningococcal C conjugate vaccine |  | 
  Concept | 104 | hepatitis A and hepatitis B vaccine |  | 
  Concept | 105 | vaccinia (smallpox) vaccine, diluted |  | 
  Concept | 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |  | 
  Concept | 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |  | 
  Concept | 108 | meningococcal ACWY vaccine, unspecified formulation |  | 
  Concept | 109 | pneumococcal vaccine, unspecified formulation |  | 
  Concept | 11 | pertussis vaccine |  | 
  Concept | 110 | DTaP-hepatitis B and poliovirus vaccine |  | 
  Concept | 111 | influenza virus vaccine, live, attenuated, for intranasal use |  | 
  Concept | 112 | tetanus toxoid, unspecified formulation |  | 
  Concept | 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
  Concept | 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |  | 
  Concept | 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |  | 
  Concept | 116 | rotavirus, live, pentavalent vaccine |  | 
  Concept | 117 |  | Version: varicella zoster immune globulin (Investigational New Drug) |  |  | 
  Concept | 118 | human papilloma virus vaccine, bivalent |  | 
  Concept | 119 | rotavirus, live, monovalent vaccine |  | 
  Concept | 12 |  | Version: diphtheria antitoxin |  |  | 
  Concept | 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
  Concept | 121 | zoster vaccine, live |  | 
  Concept | 122 | rotavirus vaccine, unspecified formulation |  | 
  Concept | 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |  | 
  Concept | 125 | Novel Influenza-H1N1-09, live virus for nasal administration |  | 
  Concept | 126 | Novel influenza-H1N1-09, preservative-free, injectable |  | 
  Concept | 127 | Novel influenza-H1N1-09, injectable |  | 
  Concept | 128 | Novel influenza-H1N1-09, all formulations |  | 
  Concept | 129 | Japanese Encephalitis vaccine, unspecified formulation |  | 
  Concept | 13 |  | Version: tetanus immune globulin |  |  | 
  Concept | 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |  | 
  Concept | 131 | Historical record of a typhus vaccination |  | 
  Concept | 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |  | 
  Concept | 133 | pneumococcal conjugate vaccine, 13 valent |  | 
  Concept | 134 | Japanese Encephalitis vaccine for intramuscular administration |  | 
  Concept | 135 | influenza, high dose seasonal, preservative-free |  | 
  Concept | 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |  | 
  Concept | 137 | HPV, unspecified formulation |  | 
  Concept | 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use |  | 
  Concept | 139 | Td(adult) unspecified formulation |  | 
  Concept | 14 |  | Version: immune globulin, unspecified formulation |  |  | 
  Concept | 140 | Influenza, seasonal, injectable, preservative free |  | 
  Concept | 141 | Influenza, seasonal, injectable |  | 
  Concept | 142 | tetanus toxoid, not adsorbed |  | 
  Concept | 143 | Adenovirus, type 4 and type 7, live, oral |  | 
  Concept | 144 | seasonal influenza, intradermal, preservative free |  | 
  Concept | 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |  | 
  Concept | 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |  | 
  Concept | 149 | influenza, live, intranasal, quadrivalent |  | 
  Concept | 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |  | 
  Concept | 150 | Influenza, injectable, quadrivalent, preservative free |  | 
  Concept | 151 | influenza nasal, unspecified formulation |  | 
  Concept | 152 | Pneumococcal Conjugate, unspecified formulation |  | 
  Concept | 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free |  | 
  Concept | 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |  | 
  Concept | 156 |  | Version: Rho(D) Immune globulin- IV or IM |  |  | 
  Concept | 157 |  | Version: Rho(D) Immune globulin - IM |  |  | 
  Concept | 158 | influenza, injectable, quadrivalent, contains preservative |  | 
  Concept | 159 |  | Version: Rho(D) Unspecified formulation |  |  | 
  Concept | 16 | influenza virus vaccine, whole virus |  | 
  Concept | 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |  | 
  Concept | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |  | 
  Concept | 162 | meningococcal B vaccine, fully recombinant |  | 
  Concept | 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted |  | 
  Concept | 164 | meningococcal B, unspecified formulation |  | 
  Concept | 165 | Human Papillomavirus 9-valent vaccine |  | 
  Concept | 166 | influenza, intradermal, quadrivalent, preservative free, injectable |  | 
  Concept | 167 | meningococcal vaccine of unknown formulation and unknown serogroups |  | 
  Concept | 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |  | 
  Concept | 169 | Hep A, live attenuated-IM |  | 
  Concept | 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |  | 
  Concept | 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
  Concept | 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |  | 
  Concept | 172 | cholera, WC-rBS |  | 
  Concept | 173 | cholera, BivWC |  | 
  Concept | 174 | cholera, live attenuated |  | 
  Concept | 175 | Human Rabies vaccine from human diploid cell culture |  | 
  Concept | 176 | Human rabies vaccine from Chicken fibroblast culture |  | 
  Concept | 177 | pneumococcal conjugate vaccine, 10 valent |  | 
  Concept | 178 | Non-US bivalent oral polio vaccine (types 1 and 3) |  | 
  Concept | 179 | Non-US monovalent oral polio vaccine, unspecified formulation |  | 
  Concept | 18 | rabies vaccine, for intramuscular injection RETIRED CODE |  | 
  Concept | 180 |  | Version: tetanus immune globulin |  |  | 
  Concept | 181 |  | Version: anthrax immune globulin |  |  | 
  Concept | 182 | Oral Polio Vaccine, Unspecified formulation |  | 
  Concept | 183 | Yellow fever vaccine alternative formulation |  | 
  Concept | 184 | Yellow fever vaccine, unspecified formulation |  | 
  Concept | 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |  | 
  Concept | 186 | Influenza, injectable, Madin Darby Canine Kidney,  quadrivalent with preservative |  | 
  Concept | 187 | zoster vaccine recombinant |  | 
  Concept | 188 | zoster vaccine, unspecified formulation |  | 
  Concept | 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted |  | 
  Concept | 19 | Bacillus Calmette-Guerin vaccine |  | 
  Concept | 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |  | 
  Concept | 21 | varicella virus vaccine |  | 
  Concept | 22 | DTP-Haemophilus influenzae type b conjugate vaccine |  | 
  Concept | 23 | plague vaccine |  | 
  Concept | 24 | anthrax vaccine |  | 
  Concept | 25 | typhoid vaccine, live, oral |  | 
  Concept | 26 | cholera vaccine, unspecified formulation |  | 
  Concept | 27 |  | Version: botulinum antitoxin |  |  | 
  Concept | 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |  | 
  Concept | 29 |  | Version: cytomegalovirus immune globulin, intravenous |  |  | 
  Concept | 30 |  | Version: hepatitis B immune globulin |  |  | 
  Concept | 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation |  | 
  Concept | 32 | meningococcal polysaccharide vaccine (MPSV4) |  | 
  Concept | 33 | pneumococcal polysaccharide vaccine, 23 valent |  | 
  Concept | 34 |  | Version: rabies immune globulin |  |  | 
  Concept | 35 | tetanus toxoid, adsorbed |  | 
  Concept | 36 |  | Version: varicella zoster immune globulin |  |  | 
  Concept | 37 | yellow fever vaccine |  | 
  Concept | 38 | rubella and mumps virus vaccine |  | 
  Concept | 39 | Japanese Encephalitis Vaccine SC |  | 
  Concept | 40 | rabies vaccine, for intradermal injection |  | 
  Concept | 41 | typhoid vaccine, parenteral, other than acetone-killed, dried |  | 
  Concept | 42 | hepatitis B vaccine, adolescent/high risk infant dosage |  | 
  Concept | 43 | hepatitis B vaccine, adult dosage |  | 
  Concept | 44 | hepatitis B vaccine, dialysis patient dosage |  | 
  Concept | 45 | hepatitis B vaccine, unspecified formulation |  | 
  Concept | 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |  | 
  Concept | 47 | Haemophilus influenzae type b vaccine, HbOC conjugate |  | 
  Concept | 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |  | 
  Concept | 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |  | 
  Concept | 50 | DTaP-Haemophilus influenzae type b conjugate vaccine |  | 
  Concept | 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |  | 
  Concept | 52 | hepatitis A vaccine, adult dosage |  | 
  Concept | 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |  | 
  Concept | 54 | adenovirus vaccine, type 4, live, oral |  | 
  Concept | 55 | adenovirus vaccine, type 7, live, oral |  | 
  Concept | 62 | human papilloma virus vaccine, quadrivalent |  | 
  Concept | 66 | Lyme disease vaccine |  | 
  Concept | 69 | parainfluenza-3 virus vaccine |  | 
  Concept | 71 |  | Version: respiratory syncytial virus immune globulin, intravenous |  |  | 
  Concept | 74 | rotavirus, live, tetravalent vaccine |  | 
  Concept | 75 | vaccinia (smallpox) vaccine |  | 
  Concept | 76 |  | Version: Staphylococcus bacteriophage lysate |  |  | 
  Concept | 77 | tick-borne encephalitis vaccine | Tick-borne encephalitis vaccine (non-US) |  | 
  Concept | 78 | tularemia vaccine |  | 
  Concept | 79 |  | Version: vaccinia immune globulin |  |  | 
  Concept | 80 | Venezuelan equine encephalitis, live, attenuated |  | 
  Concept | 801 |  | Version: AS03 Adjuvant |  |  | 
  Concept | 81 | Venezuelan equine encephalitis, inactivated |  | 
  Concept | 82 | adenovirus vaccine, unspecified formulation |  | 
  Concept | 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |  | 
  Concept | 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |  | 
  Concept | 85 | hepatitis A vaccine, unspecified formulation |  | 
  Concept | 86 |  | Version: immune globulin, intramuscular |  |  | 
  Concept | 87 |  | Version: immune globulin, intravenous |  |  | 
  Concept | 88 | influenza virus vaccine, unspecified formulation |  | 
  Concept | 89 | poliovirus vaccine, unspecified formulation |  | 
  Concept | 90 | rabies vaccine, unspecified formulation |  | 
  Concept | 91 | typhoid vaccine, unspecified formulation |  | 
  Concept | 92 | Venezuelan equine encephalitis vaccine, unspecified formulation |  | 
  Concept | 93 |  | Version: respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |  |  | 
  Concept | 94 | measles, mumps, rubella, and varicella virus vaccine |  | 
  Concept | 95 |  | Version: tuberculin skin test; old tuberculin, multipuncture device |  |  | 
  Concept | 96 |  | Version: tuberculin skin test; purified protein derivative solution, intradermal |  |  | 
  Concept | 97 |  | Version: tuberculin skin test; purified protein derivative, multipuncture device |  |  | 
  Concept | 98 |  | Version: tuberculin skin test; unspecified formulation |  |  | 
  Concept | 998 |  | Version: no vaccine administered |  |  | 
  Concept |  | 146 |  | Version: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |  | 
  Concept |  | 190 |  | Version: Typhoid conjugate vaccine (non-US) |  | 
  Concept |  | 191 |  | Version: meningococcal A polysaccharide vaccine (non-US) |  | 
  Concept |  | 192 |  | Version: meningococcal AC polysaccharide vaccine (non-US) |  | 
  Concept |  | 193 |  | Version: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |  | 
  Concept |  | 194 |  | Version: influenza, Southern Hemisphere, unspecified formulation |  | 
  Concept |  | 195 |  | Version: Diphtheria, Tetanus, Poliomyelitis adsorbed |  | 
  Concept |  | 196 |  | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |  | 
  Concept |  | 197 |  | Version: influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free |  | 
  Concept |  | 198 |  | Version: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |  | 
  Concept |  | 200 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |  | 
  Concept |  | 201 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |  | 
  Concept |  | 202 |  | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |  | 
  Concept |  | 203 |  | Version: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free |  | 
  Concept |  | 204 |  | Version: Ebola Zaire vaccine, live, recombinant, 1mL dose |  | 
  Concept |  | 205 |  | Version: influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free |  | 
  Concept |  | 206 |  | Version: Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free |  | 
  Concept |  | 207 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |  | 
  Concept |  | 208 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |  | 
  Concept |  | 210 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |  | 
  Concept |  | 211 |  | Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |  | 
  Concept |  | 212 |  | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |  | 
  Concept |  | 213 |  | Version: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |  | 
  Concept |  | 214 |  | Version: Ebola, unspecified |  | 
  Concept |  | 215 |  | Version: Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | 
  Concept |  | 216 |  | Version: Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | 
  Concept |  | 217 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |  | 
  Concept |  | 218 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |  | 
  Concept |  | 219 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |  | 
  Concept |  | 220 |  | Version: Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |  | 
  Concept |  | 221 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |  | 
  Concept |  | 222 |  | Version: Tick-borne encephalitis vaccine, unspecified |  | 
  Concept |  | 223 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |  | 
  Concept |  | 224 |  | Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |  | 
  Concept |  | 225 |  | Version: SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |  | 
  Concept |  | 227 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |  | 
  Concept |  | 228 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |  | 
  Concept |  | 229 |  | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL dose |  | 
  Concept |  | 500 |  | Version: SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |  | 
  Concept |  | 501 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |  | 
  Concept |  | 502 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |  | 
  Concept |  | 503 |  | Version: SARS-COV-2 COVID-19  Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |  | 
  Concept |  | 504 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |  | 
  Concept |  | 505 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |  | 
  Concept |  | 506 |  | Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CanSino Biological Inc./Beijing Institute of Biotechnology) |  | 
  Concept |  | 507 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |  | 
  Concept |  | 508 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product  (Jiangsu Province Centers for Disease Control and Prevention) |  | 
  Concept |  | 509 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |  | 
  Concept |  | 510 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |  | 
  Concept |  | 511 |  | Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |  | 
  Concept |  | 512 |  | Version: SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |  | 
  Concept |  | 513 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |  | 
  Concept |  | 514 |  | Version: SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |  | 
  Concept |  | 515 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |  | 
  Concept |  | 516 |  | Version: SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |  | 
  Concept |  | 517 |  | Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |  | 
  Concept |  | 56 |  | Version: dengue fever vaccine |  | 
| Code | Display | Comments | 
|---|
 01 | diphtheria, tetanus toxoids and pertussis vaccine |  | 
 02 | trivalent poliovirus vaccine, live, oral |  | 
 03 | measles, mumps and rubella virus vaccine |  | 
 04 | measles and rubella virus vaccine |  | 
 05 | measles virus vaccine |  | 
 06 | rubella virus vaccine |  | 
 07 | mumps virus vaccine |  | 
 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |  | 
 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
 10 | poliovirus vaccine, inactivated |  | 
 100 | pneumococcal conjugate vaccine, 7 valent |  | 
 101 | typhoid Vi capsular polysaccharide vaccine |  | 
 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |  | 
 103 | meningococcal C conjugate vaccine |  | 
 104 | hepatitis A and hepatitis B vaccine |  | 
 105 | vaccinia (smallpox) vaccine, diluted |  | 
 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |  | 
 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |  | 
 108 | meningococcal ACWY vaccine, unspecified formulation |  | 
 109 | pneumococcal vaccine, unspecified formulation |  | 
 11 | pertussis vaccine |  | 
 110 | DTaP-hepatitis B and poliovirus vaccine |  | 
 111 | influenza virus vaccine, live, attenuated, for intranasal use |  | 
 112 | tetanus toxoid, unspecified formulation |  | 
 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |  | 
 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |  | 
 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |  | 
 116 | rotavirus, live, pentavalent vaccine |  | 
 117 | varicella zoster immune globulin (Investigational New Drug) |  |  | 
 118 | human papilloma virus vaccine, bivalent |  | 
 119 | rotavirus, live, monovalent vaccine |  | 
 12 | diphtheria antitoxin |  |  | 
 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
 121 | zoster vaccine, live |  | 
 122 | rotavirus vaccine, unspecified formulation |  | 
 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |  | 
 125 | Novel Influenza-H1N1-09, live virus for nasal administration |  | 
 126 | Novel influenza-H1N1-09, preservative-free, injectable |  | 
 127 | Novel influenza-H1N1-09, injectable |  | 
 128 | Novel influenza-H1N1-09, all formulations |  | 
 129 | Japanese Encephalitis vaccine, unspecified formulation |  | 
 13 | tetanus immune globulin |  |  | 
 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |  | 
 131 | Historical record of a typhus vaccination |  | 
 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |  | 
 133 | pneumococcal conjugate vaccine, 13 valent |  | 
 134 | Japanese Encephalitis vaccine for intramuscular administration |  | 
 135 | influenza, high dose seasonal, preservative-free |  | 
 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |  | 
 137 | HPV, unspecified formulation |  | 
 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use |  | 
 139 | Td(adult) unspecified formulation |  | 
 14 | immune globulin, unspecified formulation |  |  | 
 140 | Influenza, seasonal, injectable, preservative free |  | 
 141 | Influenza, seasonal, injectable |  | 
 142 | tetanus toxoid, not adsorbed |  | 
 143 | Adenovirus, type 4 and type 7, live, oral |  | 
 144 | seasonal influenza, intradermal, preservative free |  | 
 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |  | 
 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |  | 
 149 | influenza, live, intranasal, quadrivalent |  | 
 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |  | 
 150 | Influenza, injectable, quadrivalent, preservative free |  | 
 151 | influenza nasal, unspecified formulation |  | 
 152 | Pneumococcal Conjugate, unspecified formulation |  | 
 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free |  | 
 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |  | 
 156 | Rho(D) Immune globulin- IV or IM |  |  | 
 157 | Rho(D) Immune globulin - IM |  |  | 
 158 | influenza, injectable, quadrivalent, contains preservative |  | 
 159 | Rho(D) Unspecified formulation |  |  | 
 16 | influenza virus vaccine, whole virus |  | 
 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |  | 
 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |  | 
 162 | meningococcal B vaccine, fully recombinant |  | 
 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted |  | 
 164 | meningococcal B, unspecified formulation |  | 
 165 | Human Papillomavirus 9-valent vaccine |  | 
 166 | influenza, intradermal, quadrivalent, preservative free, injectable |  | 
 167 | meningococcal vaccine of unknown formulation and unknown serogroups |  | 
 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |  | 
 169 | Hep A, live attenuated-IM |  | 
 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |  | 
 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |  | 
 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |  | 
 172 | cholera, WC-rBS |  | 
 173 | cholera, BivWC |  | 
 174 | cholera, live attenuated |  | 
 175 | Human Rabies vaccine from human diploid cell culture |  | 
 176 | Human rabies vaccine from Chicken fibroblast culture |  | 
 177 | pneumococcal conjugate vaccine, 10 valent |  | 
 178 | Non-US bivalent oral polio vaccine (types 1 and 3) |  | 
 179 | Non-US monovalent oral polio vaccine, unspecified formulation |  | 
 18 | rabies vaccine, for intramuscular injection RETIRED CODE |  | 
 180 | tetanus immune globulin |  |  | 
 181 | anthrax immune globulin |  |  | 
 182 | Oral Polio Vaccine, Unspecified formulation |  | 
 183 | Yellow fever vaccine alternative formulation |  | 
 184 | Yellow fever vaccine, unspecified formulation |  | 
 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |  | 
 186 | Influenza, injectable, Madin Darby Canine Kidney,  quadrivalent with preservative |  | 
 187 | zoster vaccine recombinant |  | 
 188 | zoster vaccine, unspecified formulation |  | 
 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted |  | 
 19 | Bacillus Calmette-Guerin vaccine |  | 
 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |  | 
 21 | varicella virus vaccine |  | 
 22 | DTP-Haemophilus influenzae type b conjugate vaccine |  | 
 23 | plague vaccine |  | 
 24 | anthrax vaccine |  | 
 25 | typhoid vaccine, live, oral |  | 
 26 | cholera vaccine, unspecified formulation |  | 
 27 | botulinum antitoxin |  |  | 
 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |  | 
 29 | cytomegalovirus immune globulin, intravenous |  |  | 
 30 | hepatitis B immune globulin |  |  | 
 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation |  | 
 32 | meningococcal polysaccharide vaccine (MPSV4) |  | 
 33 | pneumococcal polysaccharide vaccine, 23 valent |  | 
 34 | rabies immune globulin |  |  | 
 35 | tetanus toxoid, adsorbed |  | 
 36 | varicella zoster immune globulin |  |  | 
 37 | yellow fever vaccine |  | 
 38 | rubella and mumps virus vaccine |  | 
 39 | Japanese Encephalitis Vaccine SC |  | 
 40 | rabies vaccine, for intradermal injection |  | 
 41 | typhoid vaccine, parenteral, other than acetone-killed, dried |  | 
 42 | hepatitis B vaccine, adolescent/high risk infant dosage |  | 
 43 | hepatitis B vaccine, adult dosage |  | 
 44 | hepatitis B vaccine, dialysis patient dosage |  | 
 45 | hepatitis B vaccine, unspecified formulation |  | 
 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |  | 
 47 | Haemophilus influenzae type b vaccine, HbOC conjugate |  | 
 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |  | 
 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |  | 
 50 | DTaP-Haemophilus influenzae type b conjugate vaccine |  | 
 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |  | 
 52 | hepatitis A vaccine, adult dosage |  | 
 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |  | 
 54 | adenovirus vaccine, type 4, live, oral |  | 
 55 | adenovirus vaccine, type 7, live, oral |  | 
 62 | human papilloma virus vaccine, quadrivalent |  | 
 66 | Lyme disease vaccine |  | 
 69 | parainfluenza-3 virus vaccine |  | 
 71 | respiratory syncytial virus immune globulin, intravenous |  |  | 
 74 | rotavirus, live, tetravalent vaccine |  | 
 75 | vaccinia (smallpox) vaccine |  | 
 76 | Staphylococcus bacteriophage lysate |  |  | 
 77 | tick-borne encephalitis vaccine | Tick-borne encephalitis vaccine (non-US) | - display changed from left to right
 
  | 
 78 | tularemia vaccine |  | 
 79 | vaccinia immune globulin |  |  | 
 80 | Venezuelan equine encephalitis, live, attenuated |  | 
 801 | AS03 Adjuvant |  |  | 
 81 | Venezuelan equine encephalitis, inactivated |  | 
 82 | adenovirus vaccine, unspecified formulation |  | 
 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |  | 
 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |  | 
 85 | hepatitis A vaccine, unspecified formulation |  | 
 86 | immune globulin, intramuscular |  |  | 
 87 | immune globulin, intravenous |  |  | 
 88 | influenza virus vaccine, unspecified formulation |  | 
 89 | poliovirus vaccine, unspecified formulation |  | 
 90 | rabies vaccine, unspecified formulation |  | 
 91 | typhoid vaccine, unspecified formulation |  | 
 92 | Venezuelan equine encephalitis vaccine, unspecified formulation |  | 
 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |  |  | 
 94 | measles, mumps, rubella, and varicella virus vaccine |  | 
 95 | tuberculin skin test; old tuberculin, multipuncture device |  |  | 
 96 | tuberculin skin test; purified protein derivative solution, intradermal |  |  | 
 97 | tuberculin skin test; purified protein derivative, multipuncture device |  |  | 
 98 | tuberculin skin test; unspecified formulation |  |  | 
 998 | no vaccine administered |  |  | 
 146 |  | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |  | 
 190 |  | Typhoid conjugate vaccine (non-US) |  | 
 191 |  | meningococcal A polysaccharide vaccine (non-US) |  | 
 192 |  | meningococcal AC polysaccharide vaccine (non-US) |  | 
 193 |  | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |  | 
 194 |  | influenza, Southern Hemisphere, unspecified formulation |  | 
 195 |  | Diphtheria, Tetanus, Poliomyelitis adsorbed |  | 
 196 |  | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |  | 
 197 |  | influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |  | 
 198 |  | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |  | 
 200 |  | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |  | 
 201 |  | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |  | 
 202 |  | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |  | 
 203 |  | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |  | 
 204 |  | Ebola Zaire vaccine, live, recombinant, 1mL dose |  | 
 205 |  | influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |  | 
 206 |  | Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |  | 
 207 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |  | 
 208 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |  | 
 210 |  | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |  | 
 211 |  | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |  | 
 212 |  | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |  | 
 213 |  | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |  | 
 214 |  | Ebola, unspecified |  | 
 215 |  | Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | 
 216 |  | Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |  | 
 217 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |  | 
 218 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |  | 
 219 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |  | 
 220 |  | Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |  | 
 221 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |  | 
 222 |  | Tick-borne encephalitis vaccine, unspecified |  | 
 223 |  | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |  | 
 224 |  | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |  | 
 227 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |  | 
 228 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |  | 
 229 |  | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |  | 
 500 |  | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |  | 
 501 |  | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |  | 
 502 |  | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |  | 
 503 |  | SARS-COV-2 COVID-19  Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |  | 
 504 |  | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |  | 
 505 |  | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |  | 
 506 |  | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |  | 
 507 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |  | 
 508 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product  (Jiangsu Province Centers for Disease Control and Prevention) |  | 
 509 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |  | 
 510 |  | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |  | 
 511 |  | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |  | 
 512 |  | SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |  | 
 513 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |  | 
 514 |  | SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |  | 
 515 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |  | 
 516 |  | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |  | 
 517 |  | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |  | 
 56 |  | dengue fever vaccine, tetravalent |  |